| 1 |
34731761 | Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors. | 2022 Jan 5 |
2 |
| 2 |
35050009 | Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host. | 2022 Jan 10 |
1 |
| 3 |
33183866 | Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation. | 2021 Jan 15 |
1 |
| 4 |
34011234 | A Review of Characteristics, Properties, Application of Nanocarriers and Analytical Methods of Luliconazole. | 2021 May 19 |
1 |
| 5 |
31062656 | Molecular simulations of fluconazole-mediated inhibition of sterol biosynthesis. | 2020 Apr |
2 |
| 6 |
32220664 | Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies. | 2020 Jun |
2 |
| 7 |
32791399 | Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors. | 2020 Nov 1 |
1 |
| 8 |
33374996 | Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens. | 2020 Dec 22 |
1 |
| 9 |
31200551 | Distribution and Diversity of Cytochrome P450 Monooxygenases in the Fungal Class Tremellomycetes. | 2019 Jun 13 |
1 |
| 10 |
30076924 | Molecular modeling studies of coruscanone (A) core nucleus as potential antifungal agents. | 2018 Sep 15 |
2 |
| 11 |
30126959 | Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery. | 2018 Nov |
1 |
| 12 |
30524481 | Chemical Composition and Antifungal In Vitro and In Silico, Antioxidant, and Anticholinesterase Activities of Extracts and Constituents of Ouratea fieldingiana (DC.) Baill. | 2018 |
2 |
| 13 |
30663547 | Acute kidney injury: an unusual complication of posaconazole use. | 2018 Oct - Dec |
1 |
| 14 |
28395217 | Novel alkylated azoles as potent antifungals. | 2017 Jun 16 |
1 |
| 15 |
27161631 | The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme. | 2016 Aug |
1 |
| 16 |
27859799 | Multilocus resistance evolution to azole fungicides in fungal plant pathogen populations. | 2016 Dec |
1 |
| 17 |
27907120 | Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals. | 2016 |
2 |
| 18 |
26082652 | Efinaconazole in the treatment of onychomycosis. | 2015 |
1 |
| 19 |
23638723 | Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14α-demethylase inhibitors. | 2013 Aug |
2 |
| 20 |
19835945 | Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. | 2010 Jan |
1 |
| 21 |
17954932 | Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51. | 2007 Dec 14 |
1 |
| 22 |
16961575 | A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity. | 2006 |
1 |
| 23 |
14712470 | Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates. | 2004 Feb |
1 |
| 24 |
9661017 | NADPH cytochrome P-450 oxidoreductase and susceptibility to ketoconazole. | 1998 Jul |
1 |
| 25 |
3288361 | Cytochrome P450 of fungi: primary target for azole antifungal agents. | 1988 |
1 |